Department of Cardiac Surgery, Montreal Heart Institute and Université de Montréal, Montreal, Quebec, Canada.
Ann Thorac Surg. 2013 Sep;96(3):816-22. doi: 10.1016/j.athoracsur.2013.04.100. Epub 2013 Jul 16.
The impact of a transvalvular pacemaker lead on the progression of tricuspid regurgitation (TR) after tricuspid valve (TV) repair has not been clearly demonstrated. The aim of this study was to evaluate the presence of a transvalvular pacemaker lead as a risk factor for TR after TV repair in a large patient cohort.
A retrospective review included 791 patients who underwent TV repair at our institution from 1977 to 2008. All patients bearing a transvenous pacemaker implanted either preoperatively or within 30 days of surgery were categorized in the "PACE" group (n=176), the remaining patients were categorized in the "NO PACE" group (n=615).
Mean age was 61±11 years, and 575 patients (73%) were female. Mean follow-up was 5.8±5.5 years. Operative mortality was 13%. At discharge, TR severity was 3+ or greater in 10% and 15% of patients in the PACE and NO PACE groups, respectively (p=0.19). Multivariate analysis using a Cox regression model identified the presence of a transvenous pacemaker as an independent risk factor for recurrence of TR 2+ or greater (hazard ratio [HR] 1.60, p=0.008) and TR 3+ or greater (HR 1.47, p=0.046) at last follow-up. The presence of a transvenous pacemaker was also a significant independent predictor of late mortality (HR 2.12, p=0.02).
In patients undergoing tricuspid valve surgery, the presence of a transvenous pacemaker implanted either preoperatively or within 30 days of surgery is associated with a significantly increased risk of persistent or recurrent TR at late follow-up.
经三尖瓣(TV)修复后,跨瓣起搏器导线对三尖瓣反流(TR)进展的影响尚未明确证实。本研究旨在评估在大型患者队列中,经 TV 修复术后存在跨瓣起搏器导线是否为 TR 的危险因素。
回顾性分析了 1977 年至 2008 年在我院行 TV 修复的 791 例患者。所有术前或术后 30 天内植入经静脉起搏器的患者均归入“PACE”组(n=176),其余患者归入“NO PACE”组(n=615)。
平均年龄为 61±11 岁,575 例(73%)为女性。平均随访时间为 5.8±5.5 年。手术死亡率为 13%。出院时,PACE 组和 NO PACE 组分别有 10%和 15%的患者 TR 严重程度为 3+或更高(p=0.19)。使用 Cox 回归模型的多变量分析确定经静脉起搏器的存在是 TR 2+或更高(风险比 [HR] 1.60,p=0.008)和 TR 3+或更高(HR 1.47,p=0.046)复发的独立危险因素。经静脉起搏器的存在也是晚期死亡率的显著独立预测因素(HR 2.12,p=0.02)。
在接受三尖瓣手术的患者中,术前或术后 30 天内植入的经静脉起搏器与晚期随访时持续性或复发性 TR 的风险显著增加相关。